These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3305776)

  • 1. [Allogeneic bone marrow transplantation in the treatment of leukemia--a preliminary report].
    Chen YC; Wang CH; Lin DT; Lui PT; Cheng AL; Liu TW; Tsay W; Tien HF; Liu MC; Chuu WM
    Taiwan Yi Xue Hui Za Zhi; 1987 May; 86(5):490-6. PubMed ID: 3305776
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of cyclosporin A in 5 leukemia patients receiving allogeneic bone marrow transplantation].
    Akao Y; Sao H; Tahara T; Yoshikawa H; Yoshikawa S; Morishima Y; Hiraiwa A; Naoe T
    Rinsho Ketsueki; 1984 Sep; 25(9):1417-26. PubMed ID: 6394783
    [No Abstract]   [Full Text] [Related]  

  • 3. [Allogeneic bone marrow transplantation in 91 patients with acute leukemia (Nagoya Bone Marrow Transplantation Group)].
    Hirabayashi N; Yano K; Yokomaku S; Morishima Y; Iwamura H; Naito K; Kodera Y; Matsuyama K; Nakaide Y; Yamada H
    Rinsho Ketsueki; 1988 Mar; 29(3):313-9. PubMed ID: 3294471
    [No Abstract]   [Full Text] [Related]  

  • 4. [Improvement of allogeneic bone marrow transplantation and analysis of contributing factors].
    Mitsui H; Ohsuga Y; Nakagawa M; Teshima H; Ueda T; Hiraoka A; Nakamura H; Shibata H; Masaoka T; Ishigami S
    Rinsho Ketsueki; 1987 Nov; 28(11):1916-21. PubMed ID: 3328798
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cyclosporine in allogeneic bone marrow transplantation in children].
    Kojima S; Fukuda M; Horibe K; Matsuyama K
    Rinsho Ketsueki; 1987 Sep; 28(9):1576-82. PubMed ID: 3325658
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination of cyclosporin and methotrexate for prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation for leukemia.
    Mrsić M; Labar B; Bogdanić V; Nemet D; Pavletić Z; Plavsić F; Dobrić I; Marusić M; Francetić I; Kastelan A
    Bone Marrow Transplant; 1990 Aug; 6(2):137-41. PubMed ID: 2207450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives in marrow graft T-cell depletion in allogeneic matched related bone marrow transplantation.
    Tiberghien P; Hervé P
    Transfus Sci; 1992; 13(4):443-54. PubMed ID: 10147740
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of the microbial flora on incidence of graft-versus-host disease in human allogeneic bone marrow transplantation.
    Schmeiser T; Kurrle E; Arnold R; Heit W; Krieger D; Kubanek B; Heimpel H
    Prog Clin Biol Res; 1985; 181():433-5. PubMed ID: 3895247
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination of cyclosporine and methotrexate for prophylaxis of acute graft versus host disease after allogeneic bone marrow transplantation for leukaemias.
    Mrsić M; Labar B; Bogdanić V; Nemet D; Pavletić Z; Plavsić F; Dobrić I; Kastelan A; Marusić M; Zupancić-Salek S
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():95-6. PubMed ID: 2697416
    [No Abstract]   [Full Text] [Related]  

  • 10. Allogeneic bone marrow transplantation for acute leukemia in children. A short review.
    Masotti A; Baccarani M
    Haematologica; 1985; 70(6):536-44. PubMed ID: 3938434
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
    Socié G; Stone JV; Wingard JR; Weisdorf D; Henslee-Downey PJ; Bredeson C; Cahn JY; Passweg JR; Rowlings PA; Schouten HC; Kolb HJ; Klein JP
    N Engl J Med; 1999 Jul; 341(1):14-21. PubMed ID: 10387937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
    Martin-Algarra S; Bishop MR; Tarantolo S; Cowles MK; Reed E; Anderson JR; Vose JM; Bierman P; Armitage JO; Kessinger A
    Exp Hematol; 1995 Dec; 23(14):1503-8. PubMed ID: 8542938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved outcomes using G-CSF-mobilized blood and bone marrow grafts as the source of stem cells compared with G-PB after HLA-identical sibling transplantation in patients with acute leukemia.
    Zhao XS; Chen Y; Zhao XY; Liu DH; Xu LP; Wang Y; Han W; Chen YH; Chen H; Zhang XH; Liu KY; Huang XJ
    Clin Transplant; 2013; 27(6):844-51. PubMed ID: 23992032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
    Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
    Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic bone marrow transplantation in the treatment of human leukemia.
    Krein BM
    J Am Osteopath Assoc; 1978 Apr; 77(8):637-40. PubMed ID: 25857
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrow transplantation in standard risk adult patients with leukemia.
    Schots R; Van Riet I; Ben Othman T; Trullemans F; De Waele M; Van Camp B
    Bone Marrow Transplant; 2001 Nov; 28(10):917-22. PubMed ID: 11753544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of graft versus host disease following allogeneic bone marrow transplantation.
    Powles RL; Goss GD; Millar J; Maitland J; Borthwick-Clark C; Al-Jundi A
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):133-8. PubMed ID: 3914738
    [No Abstract]   [Full Text] [Related]  

  • 18. Allogeneic bone marrow transplantation.
    Weiden PL
    Crit Rev Clin Lab Sci; 1983; 19(3):173-86. PubMed ID: 6373140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation.
    Weiden PL; Sullivan KM; Flournoy N; Storb R; Thomas ED;
    N Engl J Med; 1981 Jun; 304(25):1529-33. PubMed ID: 7015133
    [No Abstract]   [Full Text] [Related]  

  • 20. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.
    Weiden PL; Flournoy N; Thomas ED; Prentice R; Fefer A; Buckner CD; Storb R
    N Engl J Med; 1979 May; 300(19):1068-73. PubMed ID: 34792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.